Atinum Investment | Activity | F4Atinum Investment Activity
Every public signal F4 has attached to this firm, with sources and cross-entity links.
Investment
Led ₩30B ($21M) anchor investment in Lunit's ₩200B rights offering for medical AI expansion.
Lunit
Completed liquidation of Atinum High-Growth Companies Fund with 6x MOIC, distributing 1T won to LPs.
Atinum High-Growth Companies Fund liquidation
Exit
Portfolio company IMBiologics completed IPO on Kosdaq, raising 52.0 billion KRW with 839:1 institutional oversubscription.
IMBiologics
4 investments· DEC 2025 – FEB 2026Show all
Investment
Participated in BOS Semiconductors' $60.2M Series A to commercialize AI chips for autonomous vehicles and in-vehicle systems.
BOS Semiconductors
Investment
Served as anchor investor, committing $20.98M in Lunit's 200B KRW rights offering for AI healthcare platform expansion.
Lunit
Investment
Led pre-IPO investment of 10 billion won in RideFlux, autonomous driving software startup preparing for Kosdaq listing.
RideFlux
Investment
Led Sionic AI's ₩25B Series A funding round for enterprise AI solutions.
Sionic AI
3 exits· MAY 2025 – NOV 2025Show all
Exit
Portfolio company Test Valley completed exit.
Test Valley
Exit
Portfolio company Dunamu (Upbit crypto exchange) was acquired by Naver Financial in $10.3 billion all-stock deal.
두나무
Exit
Portfolio company Organoid Sciences completed IPO on Korea Exchange (Kosdaq) with 52.38% Day 1 surge.
Organoid Sciences